BAFNAPHPharmaceuticals
Bafna Pharmaceuticals Ltd — Balance Sheet
₹109.34
-4.38%
Bafna Pharmaceuticals Ltd Balance Sheet (Annual)
| Metric | 2025 | 2024 | 2023 | 2022 | 2021 |
|---|---|---|---|---|---|
| Ordinary Shares Number | 2.37 Cr | 2.37 Cr | 2.37 Cr | 2.37 Cr | — |
| Share Issued | 2.37 Cr | 2.37 Cr | 2.37 Cr | 2.37 Cr | — |
| Net Debt | 24.77 Cr | 22.99 Cr | 15.11 Cr | 11.04 Cr | — |
| Total Debt | 28.20 Cr | 24.39 Cr | 22.92 Cr | 11.06 Cr | — |
| Tangible Book Value | 84.81 Cr | 79.07 Cr | 71.95 Cr | 61.96 Cr | — |
| Invested Capital | 113.01 Cr | 105.23 Cr | 96.38 Cr | 73.02 Cr | — |
| Working Capital | 34.33 Cr | 40.39 Cr | 40.84 Cr | 28.87 Cr | — |
| Net Tangible Assets | 84.81 Cr | 79.07 Cr | 71.95 Cr | 61.96 Cr | — |
| Common Stock Equity | 84.81 Cr | 80.84 Cr | 73.45 Cr | 61.96 Cr | — |
| Total Capitalization | 98.83 Cr | 91.59 Cr | 81.89 Cr | 67.28 Cr | — |
| Total Equity Gross Minority Interest | 84.81 Cr | 80.84 Cr | 73.45 Cr | 61.96 Cr | — |
| Stockholders Equity | 84.81 Cr | 80.84 Cr | 73.45 Cr | 61.96 Cr | — |
| Other Equity Interest | 61.15 Cr | 57.18 Cr | 49.80 Cr | 39.22 Cr | — |
| Capital Stock | 23.66 Cr | 23.66 Cr | 23.66 Cr | 23.66 Cr | — |
| Common Stock | 23.66 Cr | 23.66 Cr | 23.66 Cr | 23.66 Cr | — |
| Total Liabilities Net Minority Interest | 68.27 Cr | 66.84 Cr | 56.13 Cr | 28.18 Cr | — |
| Total Non Current Liabilities Net Minority Interest | 16.42 Cr | 12.76 Cr | 9.65 Cr | 6.17 Cr | — |
| Non Current Deferred Revenue | 1.91 Cr | 1.61 Cr | 1.22 Cr | 0.85 Cr | — |
| Long Term Debt And Capital Lease Obligation | 14.03 Cr | 10.75 Cr | 8.43 Cr | 5.32 Cr | — |
| Long Term Debt | 14.03 Cr | 10.75 Cr | 8.43 Cr | 5.32 Cr | — |
| Long Term Provisions | 0.48 Cr | 0.39 Cr | — | — | — |
| Current Liabilities | 51.85 Cr | 54.08 Cr | 46.48 Cr | 22.01 Cr | — |
| Other Current Liabilities | 2.60 Cr | 1.83 Cr | 2.12 Cr | 2.15 Cr | — |
| Current Debt And Capital Lease Obligation | 14.17 Cr | 13.64 Cr | 14.49 Cr | 5.74 Cr | — |
| Current Debt | 14.17 Cr | 13.64 Cr | 14.49 Cr | 5.74 Cr | — |
| Current Provisions | 1.38 Cr | 1.26 Cr | 1.25 Cr | — | — |
| Payables | 30.95 Cr | 38.92 Cr | 30.59 Cr | 14.64 Cr | — |
| Accounts Payable | 30.95 Cr | 35.42 Cr | 28.46 Cr | 12.40 Cr | — |
| Total Assets | 153.08 Cr | 147.68 Cr | 129.58 Cr | 90.14 Cr | — |
| Total Non Current Assets | 66.90 Cr | 53.21 Cr | 42.27 Cr | 39.26 Cr | — |
| Investmentin Financial Assets | 0.81 Cr | 0.00 | 0.00 | 0.00 | — |
| Available For Sale Securities | 0.81 Cr | 0.73 Cr | 0.54 Cr | — | — |
| Goodwill And Other Intangible Assets | 0.00 | 1.77 Cr | 1.50 Cr | 0.00 | — |
| Net PPE | 66.09 Cr | 50.71 Cr | 40.23 Cr | 38.85 Cr | — |
| Gross PPE | 66.09 Cr | 109.98 Cr | 94.66 Cr | 87.94 Cr | — |
| Construction In Progress | 7.31 Cr | 10.50 Cr | 0.00 | 0.00 | — |
| Other Properties | 58.78 Cr | 14.85 Cr | 14.13 Cr | 13.11 Cr | — |
| Current Assets | 86.18 Cr | 94.47 Cr | 87.31 Cr | 50.88 Cr | — |
| Other Current Assets | 12.71 Cr | 16.61 Cr | 15.60 Cr | 16.17 Cr | — |
| Assets Held For Sale Current | 1.45 Cr | — | — | 0.00 | 0.00 |
| Inventory | 28.09 Cr | 29.64 Cr | 22.22 Cr | 20.28 Cr | — |
| Other Receivables | 0.02 Cr | 0.08 Cr | 0.05 Cr | 0.10 Cr | — |
| Taxes Receivable | 0.30 Cr | 15.39 Cr | 14.27 Cr | 14.73 Cr | — |
| Accounts Receivable | 40.17 Cr | 45.39 Cr | 41.15 Cr | 14.78 Cr | — |
| Cash Cash Equivalents And Short Term Investments | 3.43 Cr | 2.10 Cr | 7.81 Cr | 0.02 Cr | — |
| Cash And Cash Equivalents | 3.43 Cr | 1.40 Cr | 7.81 Cr | 0.02 Cr | — |
| Retained Earnings | — | -47.10 Cr | -54.48 Cr | -65.97 Cr | -71.17 Cr |
| Additional Paid In Capital | — | 75.38 Cr | 75.38 Cr | 75.38 Cr | 75.38 Cr |
| Other Non Current Liabilities | — | 3000.00 | — | 1.07 Cr | 1000.00 |
| Other Payable | — | 3.28 Cr | 2.05 Cr | 2.15 Cr | — |
| Total Tax Payable | — | 0.22 Cr | 0.08 Cr | 0.09 Cr | 0.08 Cr |
| Other Non Current Assets | — | -2000.00 | -3000.00 | -2000.00 | -2000.00 |
| Non Current Prepaid Assets | — | 0.73 Cr | 0.54 Cr | 0.42 Cr | — |
| Other Intangible Assets | — | 1.77 Cr | 1.50 Cr | — | — |
| Accumulated Depreciation | — | -59.28 Cr | -54.43 Cr | -49.09 Cr | -43.60 Cr |
| Machinery Furniture Equipment | — | 59.29 Cr | 55.25 Cr | 50.06 Cr | 17.53 Cr |
| Buildings And Improvements | — | 25.15 Cr | 25.08 Cr | 24.57 Cr | 22.54 Cr |
| Land And Improvements | — | 0.19 Cr | 0.19 Cr | 0.19 Cr | 0.19 Cr |
| Properties | — | 0.00 | 0.00 | 0.00 | 0.00 |
| Prepaid Assets | — | 1.87 Cr | 1.81 Cr | 0.82 Cr | 11.27 Cr |
| Inventories Adjustments Allowances | — | 0.00 | 0.00 | — | — |
| Finished Goods | — | 3.06 Cr | 2.19 Cr | 3.24 Cr | 1.68 Cr |
| Work In Process | — | 9.13 Cr | 5.15 Cr | 1.19 Cr | 0.97 Cr |
| Raw Materials | — | 17.45 Cr | 14.88 Cr | 15.85 Cr | 10.06 Cr |
| Allowance For Doubtful Accounts Receivable | — | -0.89 Cr | -0.37 Cr | 0.00 | — |
| Gross Accounts Receivable | — | 46.29 Cr | 41.52 Cr | 14.78 Cr | 9.56 Cr |
| Other Short Term Investments | — | 0.70 Cr | — | — | — |
| Cash Equivalents | — | 1.33 Cr | 7.68 Cr | 0.00 | 0.00 |
| Cash Financial | — | 0.07 Cr | 0.13 Cr | 0.02 Cr | 0.75 Cr |
| Pensionand Other Post Retirement Benefit Plans Current | — | — | 0.63 Cr | 1.56 Cr | 0.00 |
| Restricted Cash | — | — | 1.15 Cr | 0.15 Cr | 1.06 Cr |
| Minority Interest | — | — | — | 0.00 | 0.00 |
| Non Current Pension And Other Postretirement Benefit Plans | — | — | — | 0.97 Cr | 0.00 |
| Tradeand Other Payables Non Current | — | — | — | 2.12 Cr | 2.89 Cr |
| Non Current Deferred Taxes Liabilities | — | — | — | 0.00 | 0.00 |
| Goodwill | — | — | — | 0.00 | 0.00 |
| Other Inventories | — | — | — | 3.67 Cr | 2.73 Cr |
All figures in ₹ Crores. Source: NSE/BSE filings via Bull Run.
More on Bafna Pharmaceuticals Ltd
Data from NSE/BSE public filings. Educational purposes only. Bull Run is not SEBI-registered. Not investment advice.